Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001101669.3(INPP4B):c.2260C>A(p.Gln754Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000164 in 1,460,686 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
INPP4B (HGNC:6075): (inositol polyphosphate-4-phosphatase type II B) INPP4B encodes the inositol polyphosphate 4-phosphatase type II, one of the enzymes involved in phosphatidylinositol signaling pathways. This enzyme removes the phosphate group at position 4 of the inositol ring from inositol 3,4-bisphosphate. There is limited data to suggest that the human type II enzyme is subject to alternative splicing, as has been established for the type I enzyme. [provided by RefSeq, Jul 2008]
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The c.2260C>A (p.Q754K) alteration is located in exon 23 (coding exon 19) of the INPP4B gene. This alteration results from a C to A substitution at nucleotide position 2260, causing the glutamine (Q) at amino acid position 754 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Gain of ubiquitination at Q754 (P = 0.0177);Gain of ubiquitination at Q754 (P = 0.0177);Gain of ubiquitination at Q754 (P = 0.0177);Gain of ubiquitination at Q754 (P = 0.0177);.;Gain of ubiquitination at Q754 (P = 0.0177);.;